QNME

What one share of Quanome Technologies holds

Arrangement of Transportation of Freight and Cargo

Prior to February 12, 2026, in addition to engaging in the distribution of pharmaceutical products through Hupan Pharmaceutical, we also operated as a U.S.-based integrated cross-border supply chain solutions provider with a strategic focus on the Asian market.

Quanome Technologies’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.23
Profit−$0.37
Capex (buildings and equipment)$0.00
Free cash flow−$0.12
Cash and investments$0.02
Debt$0.00
Book value$0.20

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2023$2.15$0.16$0.00$0.00—$0.14
2024$3.05−$0.04———$0.11
2025$0.37−$0.69$0.00−$0.35—$0.27
2026$0.23−$0.37$0.00−$0.12—$0.20

Common questions about Quanome Technologies

How much does one share of Quanome Technologies earn?

Over its latest fiscal year, Quanome Technologies lost $0.37 for each share on $0.23 of sales.

Does Quanome Technologies pay a dividend?

Quanome Technologies didn’t pay a dividend over its latest fiscal year, according to its SEC filings.

What is Quanome Technologies’s book value per share?

Quanome Technologies’s book value is $0.20 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Quanome Technologies have?

Each share of Quanome Technologies has $0.02 of cash and investments and $0.00 of debt, as of June 30, 2026.

What is Quanome Technologies’s free cash flow per share?

−$0.12 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.

Has Quanome Technologies bought back shares?

Quanome Technologies’s share count rose about 329% from 2023 to 2026. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.